April 4, 2019 — Pfizer (NYSE:PFE) today announced that the U.S. Food and Drug Administration…
View More FDA Approves Ibrance (palbociclib) for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer
Home »
Surgery is associated with increased survival for patients with HER2+ stage 4 breast cancer
Surgery was associated with higher survival rates for patients with HER2-positive (HER2+) stage 4 breast…
View More Surgery is associated with increased survival for patients with HER2+ stage 4 breast cancer